The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans

In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Health Literacy Month

Celebrating Health Literacy Month 2024:

October is Health Literacy Month, a reminder of the...
Medication without Harm

World Patient Safety Day 2022 – Medication Without Harm

Medication use around the world has increased in the last few years; a 2019 CDC...
Patient Inclusivity Survey - PM360 and Cactus Life Sciences

Patient Inclusivity Survey

How many life sciences companies are actually making an effort to include patients in things...
Caregivers, Patient Engagement Day

World Patient Engagement Day 2022

Caregivers play a crucial role in ensuring patient well-being.This World Patient Engagement Day, let’s take...
Why the Healthcare Industry MUST Care About the Caregiver

Why the Healthcare Industry MUST Care about the Caregiver

Caregivers are vital in the treatment of a patient, whether at home or in a...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered A Survey of Industry Professionals

Understanding Patient Centricity, Progress Made, and Barriers Encountered: A Survey of Industry Professionals

Cactus Life Sciences conducted a survey of pharma/biotech and associated industry professionals to gather their...
Image - What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better

What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?

While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...

Learn more ABOUT our company.